OTR Tablet 40 mg Fasted-state Bioequivalence Study
Status:
Completed
Trial end date:
2018-03-20
Target enrollment:
Participant gender:
Summary
This is an open-label, single dose, randomised, cross-over study to confirm the
bioequivalence (BE) of OTR tablet 40 mg and OXYCONTIN tablet 40 mg in a fasted state in
Chinese subjects with chronic pain